{"id":54412,"date":"2026-05-14T11:02:59","date_gmt":"2026-05-14T05:32:59","guid":{"rendered":"https:\/\/financialtelegraph.in\/index.php\/2026\/05\/14\/krishnas-ayurveda-she-care-juice-clinically-proven-to-support-pcod-management-in-90-days\/"},"modified":"2026-05-14T11:02:59","modified_gmt":"2026-05-14T05:32:59","slug":"krishnas-ayurveda-she-care-juice-clinically-proven-to-support-pcod-management-in-90-days","status":"publish","type":"post","link":"https:\/\/financialtelegraph.in\/index.php\/2026\/05\/14\/krishnas-ayurveda-she-care-juice-clinically-proven-to-support-pcod-management-in-90-days\/","title":{"rendered":"Krishna\u2019s Ayurveda, She Care Juice Clinically Proven to Support PCOD Management in 90 Days"},"content":{"rendered":"<div>\n<p><img loading=\"lazy\" width=\"1200\" height=\"675\" src=\"https:\/\/financialtelegraph.in\/wp-content\/uploads\/2026\/05\/PNN-2026-05-12T200157917.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Krishna\" decoding=\"async\"><\/p>\n<p><strong>Jodhpur (Rajasthan) [India], May 12: In a step that brings traditional Ayurveda closer to modern clinical validation, <a href=\"https:\/\/krishna64.gotrackier.io\/click?campaign_id=1&amp;pub_id=91&amp;source=PR_Clinicallyproven&amp;url=https%3A%2F%2Fkrishnaayurved.com%2Fproducts%2Fshe-care-juice\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/krishna64.gotrackier.io\/click\" rel=\"noreferrer noopener nofollow\">Krishna\u2019s Herbal &amp; Ayurveda<\/a> has announced the successful completion of a clinical study on its<\/strong>\u00a0<strong>She Care Juice<\/strong>, designed to support women dealing with PCOD-related concerns.<\/p>\n<p>For millions of women, PCOD is not just a medical term. It often shows up as irregular periods, acne, unwanted facial hair, weight gain, emotional stress, and a constant feeling that the body is out of balance. With She Care Juice, Krishna\u2019s Ayurveda has focused on a formulation that supports women\u2019s health naturally, while now also being backed by clinical observation.<\/p>\n<p>The study was conducted as a\u00a0<strong>prospective, open-label, single-arm clinical study over 90 days<\/strong>\u00a0among women diagnosed with PCOD. The findings showed meaningful improvements across key PCOD-related symptoms. The mean\u00a0mFG\u00a0score, used to assess hirsutism, reduced from\u00a0<strong>11.53 to 4.88<\/strong>\u00a0by Day 90. Acne severity also improved significantly, with\u00a0<strong>100% of participants achieving clear or almost clear skin<\/strong>\u00a0by the end of the study period. Participants also recorded improvements in weight, BMI, waist circumference, menstrual symptoms, and overall quality of life.<\/p>\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1200\" height=\"675\" src=\"https:\/\/financialtelegraph.in\/wp-content\/uploads\/2026\/05\/PNN-2026-05-12T174841128.jpg\" alt=\"\" class=\"wp-image-76172\"><\/figure>\n<\/div>\n<p>Speaking on the milestone,\u00a0<strong>Mr.\u00a0Shrawan\u00a0Daga, Founder &amp; CEO of Krishna\u2019s Herbal &amp; Ayurveda<\/strong>, said,\u00a0<em>\u201cThis clinical milestone is a proud moment for us. It validates our belief that Ayurveda, when backed by scientific research, can deliver safe and effective solutions for modern health challenges like PCOD. She Care Juice is not just a product, it\u2019s a step towards holistic, root-cause wellness for women.\u201d<\/em><\/p>\n<p>The study also reported positive hormonal trends, including a decrease in the LH\/FSH ratio among several participants, while metabolic markers remained stable. Importantly,\u00a0no adverse events or serious adverse events were reported, and liver, kidney, thyroid, haematological parameters, and vital signs remained clinically stable throughout the study.<\/p>\n<p>With this clinical milestone, <strong><a href=\"https:\/\/krishna64.gotrackier.io\/click?campaign_id=1&amp;pub_id=91&amp;source=PR_Clinicallyproven&amp;url=https%3A%2F%2Fkrishnaayurved.com%2Fproducts%2Fshe-care-juice\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/krishna64.gotrackier.io\/click\" rel=\"noreferrer noopener nofollow\">Krishna\u2019s Ayurveda <\/a><\/strong>aims to strengthen confidence among women looking for a natural, daily wellness support for PCOD management. The brand believes She Care Juice can become a trusted addition to a holistic routine that includes balanced nutrition, lifestyle correction, regular movement, and medical guidance wherever required.<\/p>\n<p><em><strong><em>Disclaimer: <\/em><\/strong><em>This press release is for general information purposes only and should not be construed as professional medical advice. Always consult a doctor before taking any decisions.<\/em><\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Jodhpur (Rajasthan) [India], May 12: In a step that brings traditional Ayurveda closer to modern clinical validation, Krishna\u2019s Herbal &amp; Ayurveda has announced the successful completion of a clinical study &hellip; <a href=\"https:\/\/financialtelegraph.in\/index.php\/2026\/05\/14\/krishnas-ayurveda-she-care-juice-clinically-proven-to-support-pcod-management-in-90-days\/\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":54413,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[99],"tags":[680],"class_list":["post-54412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-health","entry"],"_links":{"self":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/54412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/comments?post=54412"}],"version-history":[{"count":0,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/54412\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media\/54413"}],"wp:attachment":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media?parent=54412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/categories?post=54412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/tags?post=54412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}